(Q37975158)

26 August 2017

title

Nonalcoholic fatty liver disease in pediatric patients (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

26 August 2017

0 references

1 reference

1 reference

Frank R Sinatra

1

1 reference

26 August 2017

publication date

1 January 2012

1 reference

Journal of Parenteral and Enteral Nutrition

26 August 2017

published in

1 reference

26 August 2017

volume

36

1 reference

26 August 2017

issue

1 Suppl

1 reference

26 August 2017

page(s)

43S-8S

1 reference

Complications of obesity in children and adolescents

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Prevalence of fatty liver in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Plasma adiponectin is decreased in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607111421610

21 January 2018

Identifiers

DOI

10.1177/0148607111421610

1 reference

26 August 2017

1 reference